TriangleFOR PATIENTS · SOURCE READING
Treatment of Childhood Medulloblastoma
Source: Childhood Medulloblastoma and Other Central Nervous System Embryonal Tumors Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: December 2, 2024 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
For information about the treatments listed below, see the Treatment Option Overview section.
Source links and citations
Younger children with medulloblastoma
Treatment of newly diagnosed medulloblastoma in children aged 3 years and younger includes:
Source links and citations
Surgery to remove as much of the tumor as possible, followed by chemotherapy.
Other treatments that may be given after surgery include:
High-dose systemic and intraventricular chemotherapy.
Source links and citations
High-dose chemotherapy with stem cell rescue.
Source links and citations
Chemotherapy with or without radiation therapy to the area where the tumor was removed.
Children older than 3 years with average-risk medulloblastoma
Treatment of newly diagnosed average-risk medulloblastoma in children older than 3 years includes:
Surgery to remove as much of the tumor as possible. This is followed by radiation therapy to the brain and spinal cord. Chemotherapy may also be given during and after radiation therapy.
Surgery to remove the tumor, radiation therapy, and high-dose chemotherapy with stem cell rescue.
Children older than 3 years with high-risk medulloblastoma
Treatment of newly diagnosed high-risk medulloblastoma in children older than 3 years includes:
Surgery to remove as much of the tumor as possible. This is followed by a larger dose of radiation therapy to the brain and spinal cord than the dose given for average-risk medulloblastoma. Chemotherapy is also given during and after radiation therapy.
Surgery to remove the tumor, radiation therapy, and high-dose chemotherapy with stem cell rescue.
Preserved source evidence · Independent clinical review pending · Not medical advice